ティシューバイネット株式会社
Site unreachableTissue by Net is a contract manufacturer producing cell blocks from client-provided cells and media, with fibroblasts and MSCs as standards.
What it does
"Tissue by Net is a Medtech company specializing in the production of cell blocks using a revolutionary method known as the Net Mold technique. This innovative approach leverages cell adhesion to create 3D cell blocks where cells adhere closely together, forming natural tissue structures with sufficient strength and cytokine production. The technology holds promise for a wide range of applications, including alternatives to animal testing, infertility treatments, and artificial organ development. Tissue by Net offers a range of products, including the Net Mold Starter Kit and various items necessary for cell block production. With the potential for medical applications indicated by published papers and research findings, Tissue by Net is at the forefront of advancing tissue engineering solutions in the Medtech industry."
Next to it in Healthcare and bio · 3D cell tissue manufacturing
- Meccellis BiotechPlug and Play
Meccellis Biotech specializes in tissue and cell engineering.
- 株式会社セルファイバPlug and Play
Cell fiber technology was developed as a basic technology for handling cells in the engineering field.
- Asuka MedicalPlug and Play
Asuka Medical is a professional manufacturer of medical laser equipment.
- 株式会社サイフューズPlug and Play
Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally.
- ハインツテック株式会社Plug and Play
Hynts Tech manufactures tools and systems for extracting intracellular substances or introducing arbitary substances such as protein.
- NodexusPlug and Play
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
- TissueFormPlug and Play
TissueForm develops tissue-based biomaterials and implants that replicate extracellular matrix to repair tissue loss.
- X-ZellY Combinator W15
Early, pain-free cancer detection.